CDER Snapshots Offer Clearer Picture Of Pivotal Trial Subgroup Data
Executive Summary
Race-based enrollment disparities could put more pressure on industry to broaden trial recruitment, but FDA’s demographic data transparency initiative also could help companies differentiate their products.